BOME Therapeutics

Chemicals & Related Products · New Jersey, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1122 High St N, Millville, New Jersey, 0...

Revenue

<$5 Million

Industry

Chemicals & Related Products Manufacturing Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About BOME Therapeutics

BOME Therapeutics is pioneering the development of the world's first and only allergen vaccine specifically targeting poison ivy and poison oak allergies. Utilizing a proprietary process, the company aims to advance allergen immunotherapy by effectively signaling the immune system to build tolerance and reduce sensitivity to these allergens. With approximately 175 million Americans seeking medical attention for related allergy issues each year, BOME's innovative approach addresses a significant unmet need in allergy treatment. Currently, the immunotherapy is not FDA approved, but the company is refining its product and plans to conduct clinical trials in the near future.Explore more
Popular SearchesBOME TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

BOME Therapeutics Org Chart

HK
United States flag for contact location.

Chief Executive Officer

PhoneEmail

Is BOME Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

BOME Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

BOME Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BOME Therapeutics.

Top Chemicals & Related Products Companies

Frequently Asked Questions Regarding BOME Therapeutics

What is BOME Therapeutics's official website?
BOME Therapeutics's official website is www.bomepharma.com
What is BOME Therapeutics's Revenue?
BOME Therapeutics's revenue is <$5 Million
What is BOME Therapeutics's SIC code?
BOME Therapeutics's SIC: 28,283
What is BOME Therapeutics's NAICS code?
BOME Therapeutics's NAICS: 32,325
How many employees does BOME Therapeutics have?
BOME Therapeutics has 11-50 employees
What industry does BOME Therapeutics belong to?
BOME Therapeutics is in the industry of: Chemicals & Related Products, Manufacturing, Business Services
What does BOME Therapeutics do?

BOME Therapeutics is pioneering the development of the world's first and only allergen vaccine specifically targeting poison ivy and poison oak allergies. Utilizing a proprietary process, the company aims to advance allergen immunotherapy by effectively signaling the immune system to build tolerance and reduce sensitivity to these allergens. With a... pproximately 175 million Americans seeking medical attention for related allergy issues each year, BOME's innovative approach addresses a significant unmet need in allergy treatment. Currently, the immunotherapy is not FDA approved, but the company is refining its product and plans to conduct clinical trials in the near future.Read More

Is BOME Therapeutics a public company?
BOME Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about BOME Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.